3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
5
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
Mammography
12
Radiofrequency Ablation
9
Blood Specimen Collection
9
Standard of Care
8
Drug Delivery Systems
8
Colonoscopy
8
Uterine Myomectomy
6
Robotic Surgical Procedures
6
Cryosurgery
6
Colposcopy
6
Biopsy
6
Proton Therapy
5
Inositol
5
Therapeutics
4
Surgical Procedures, Operative
4
Radiotherapy
4
Leukapheresis
4
Food
4
Drug Therapy
4
Cryotherapy
4
Cisplatin
4
CF regimen
4
Brachytherapy
4
pegylated granulocyte colony-stimulating factor
3
exemestane
3
epigallocatechin gallate
3
Uterine Artery Embolization
3
Sunitinib
3
Paclitaxel
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
INDUSTRY
×
Hysterectomy
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled